Live
- Garena Free Fire MAX Redeem Codes for December 28, 2024: Get Frostfire Bunny Bundle, Rose Emote, and Exclusive Rewards!
- Salman Khan Faces Off Against Samurais in Action-Packed Teaser for 'Sikandar'
- Putin apologises to Azerbaijan's Aliyev for 'tragic' plane crash
- OnePlus Open 2 Leaks: Exciting Upgrades in Design, Features, and Performance
- Pioneering database excellence: Dheeraj Yadav's journey through enterprise data management
- Rajasthan Government Dissolves Nine Districts in Key Cabinet Decision
- HYDRAA's 2024 Report: 5800 Complaints Resolved, 12 Lakes Restored, and 200 Acres Reclaimed in Hyderabad
- Revolutionizing marketplace pricing with Machine Learning: The strategic innovation of Abhijeet Bajaj
- AI-powered transformation in manufacturing: Balachandar Ramalingam's vision for component management excellence
- Mangaluru Kambala 2024 Inaugurated, Showcases Buffalo Racing and More
Biotech plays key role in combating chronic diseases: SVU VC
A three-day international conference on ‘Biotechnology, Medicine and Cancer Therapeutics’ began on Friday at Sri Venkateswara Univer-sity, organised...
A three-day international conference on ‘Biotechnology, Medicine and Cancer Therapeutics’ began on Friday at Sri Venkateswara Univer-sity, organised in collaboration with the University of Alabama, USA and its Department of Biotechnology.
The event was inaugurated by Vice-Chancellor Prof Ch Appa Rao, who emphasised the role of biotechnology in combating chronic diseases like cancer. Speaking at the event, he stated, "The development of bi-otechnology holds the key to providing effective treatment for stub-born diseases like cancer, which currently lack adequate therapeutic methods and drugs. Through advanced biotechnology, we can design better treatment protocols and innovative drug solutions".
The keynote address was delivered by Dr Malla Mithun of the Univer-sity of Alabama, who highlighted significant progress in managing colorectal cancer. "Notable advancements have been made, particu-larly in addressing Microsatellite Stable (MSS) metastatic colorectal carcinoma (mCRC).
